Kynam Capital Management as of June 30, 2024
Portfolio Holdings for Kynam Capital Management
Kynam Capital Management holds 26 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Natera (NTRA) | 16.8 | $218M | 2.0M | 108.29 | |
| Vertex Pharmaceuticals Incorporated Put Option (VRTX) | 11.9 | $155M | 330k | 468.72 | |
| Celldex Therapeutics Com New (CLDX) | 9.7 | $125M | 3.4M | 37.01 | |
| Syndax Pharmaceuticals (SNDX) | 9.1 | $118M | 5.7M | 20.53 | |
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 8.4 | $109M | 200k | 545.50 | |
| Dynavax Technologies Corp Com New (DVAX) | 6.1 | $80M | 7.1M | 11.23 | |
| Cogent Biosciences (COGT) | 6.0 | $78M | 9.3M | 8.43 | |
| Insmed Com Par $.01 Call Option (INSM) | 5.2 | $67M | 1.0M | 67.00 | |
| Vaxcyte (PCVX) | 4.4 | $57M | 753k | 75.51 | |
| Vera Therapeutics Cl A (VERA) | 4.3 | $56M | 1.5M | 36.18 | |
| BioCryst Pharmaceuticals (BCRX) | 4.2 | $55M | 8.8M | 6.18 | |
| Protagonist Therapeutics (PTGX) | 2.1 | $28M | 800k | 34.65 | |
| 2seventy Bio Common Stock | 1.8 | $23M | 6.0M | 3.85 | |
| Miragen Therapeutics (VRDN) | 1.8 | $23M | 1.8M | 13.01 | |
| Wave Life Sciences SHS (WVE) | 1.5 | $20M | 4.0M | 4.99 | |
| Travere Therapeutics (TVTX) | 1.3 | $17M | 2.0M | 8.22 | |
| Liquidia Corporation Com New (LQDA) | 0.8 | $11M | 917k | 12.00 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.8 | $11M | 1.6M | 6.52 | |
| Alnylam Pharmaceuticals Put Option (ALNY) | 0.8 | $10M | 43k | 243.00 | |
| Tyra Biosciences (TYRA) | 0.7 | $9.1M | 567k | 15.99 | |
| Amarin Corp Spons Adr New | 0.6 | $8.4M | 12M | 0.69 | |
| Burning Rock Biotech Sponsored Ads (BNR) | 0.5 | $6.3M | 975k | 6.45 | |
| Sutro Biopharma | 0.5 | $5.9M | 2.0M | 2.93 | |
| Acelyrin | 0.3 | $3.7M | 831k | 4.41 | |
| Caribou Biosciences (CRBU) | 0.2 | $2.7M | 1.6M | 1.64 | |
| Cg Oncology (CGON) | 0.1 | $1.7M | 54k | 31.57 |
